- Lobbying
- Lobbying by Rayner
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Jeanne Haggerty | Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member |
Karina Lynch | Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs |
Kurt Schrader | Former Member of Congress |
Alec Aramanda | Prof Staff, House Cmtee on E&C; Dir Ofc of Legislation & Dir Stakeholder Engagement, Centers for Medicare & Medicaid Services; Deputy Assistant Secretary for Health Policy, Department of Health & Human Services; Domestic Policy Advisor, Deputy Legislative Director, Leg Asst, Sen. Cruz; Leg Asst, Sen. DeMint |
Laura Simmons | Advisor, Office of Legislative Affairs, Dept of Homeland Security |
Susan Hirschmann | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Registration
Issue(s) they said they’d lobby about: Williams and Jensen will be lobbying on behalf of ensuring adequate CMS coverage and reimbursement of Rayner's non-opioid product and build support for the reauthorization for the No Plan Act and other related legislations..
Registration
Issue(s) they said they’d lobby about: Williams and Jensen will be lobbying on behalf of ensuring adequate CMS coverage and reimbursement of Rayner's non-opioid product and build support for the reauthorization for the No Plan Act and other related legislations..
Registration
Issue(s) they said they’d lobby about: Williams and Jensen will be lobbying on behalf of ensuring adequate CMS coverage and reimbursement of Rayner's non-opioid product and build support for the reauthorization for the No Plan Act and other related legislations..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate